Literature DB >> 17093293

Age-related impairment of HDL-mediated cholesterol efflux.

Hicham Berrougui1, Maxim Isabelle, Martin Cloutier, Guillaume Grenier, Abdelouahed Khalil.   

Abstract

Our aim in this study was to investigate the effect of aging on the capacity of HDLs to promote reverse cholesterol transport. HDLs were isolated from plasma of young (Y-HDL) and elderly (E-HDL) subjects. HDL-mediated cholesterol efflux was studied using THP-1 and J774 macrophages. Our results show that E-HDLs present a lower capacity to promote cholesterol efflux than Y-HDLs (41.7 +/- 1.4% vs. 49.0 +/- 2.2%, respectively; P = 0.013). Reduction in the HDL-mediated cholesterol efflux capacity with aging was more significant with HDL(3) than HDL(2) (Y-HDL(3), 57.3 +/- 1% vs. E-HDL(3), 50.9 +/- 2%; P = 0.012). Moreover, our results show that ABCA1-mediated cholesterol efflux is the more affected pathway in terms of cholesterol-removing capacity. Interestingly, the composition and structure of HDL revealed a reduction in the phosphatidylcholine-sphingomyelin ratio (E-HDL, 32.7 +/- 2.7 vs. Y-HDL, 40.0 +/- 1.9; P = 0.029) and in the phospholipidic layer membrane fluidity in E-HDL compared with Y-HDL as well as an alteration in the apolipoprotein A-I structure and charge. In conclusion, our results shown that E-HDLs present a reduced capacity to promote cholesterol efflux, principally through the ABCA1 pathway, and this may explain the increase of the incidence of cardiovascular diseases observed during aging.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17093293     DOI: 10.1194/jlr.M600167-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  27 in total

1.  The effect of 17β-estradiol on cholesterol content in human macrophages is influenced by the lipoprotein milieu.

Authors:  Michael P Corcoran; Alice H Lichtenstein; Mohsen Meydani; Alice Dillard; Ernst J Schaefer; Stefania Lamon-Fava
Journal:  J Mol Endocrinol       Date:  2011-08       Impact factor: 5.098

2.  Cholesterol efflux capacity does not associate with coronary calcium, plaque vulnerability, and telomere length in healthy octogenarians.

Authors:  Francesca Zimetti; Wladimir M Freitas; Alessandra M Campos; Mauricio Daher; Maria Pia Adorni; Franco Bernini; Andrei C Sposito; Ilaria Zanotti
Journal:  J Lipid Res       Date:  2018-02-07       Impact factor: 5.922

3.  Age is positively associated with high-density lipoprotein cholesterol among African Americans in cross-sectional analysis: the Jackson Heart Study.

Authors:  Jane L Harman; Michael E Griswold; Neal O Jeffries; Anne E Sumner; Daniel F Sarpong; Ermeg L Akylbekova; Evelyn R Walker; Sharon B Wyatt; Herman A Taylor
Journal:  J Clin Lipidol       Date:  2011-03-02       Impact factor: 4.766

4.  A novel fatty acid lipophilic index and risk of CHD in US men: the health professionals follow-up study.

Authors:  Hongyu Wu; Eric L Ding; Estefanía T Toledo; Hannia Campos; Ana Baylin; Frank B Hu; Qi Sun
Journal:  Br J Nutr       Date:  2013-01-08       Impact factor: 3.718

5.  HDL (High-Density Lipoprotein) Metrics and Atherosclerotic Risk in Women.

Authors:  Samar R El Khoudary; Indre Ceponiene; Saad Samargandy; James H Stein; Dong Li; Matthew C Tattersall; Matthew J Budoff
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-09       Impact factor: 8.311

6.  Higher Lipophilic Index Indicates Higher Risk of Coronary Heart Disease in Postmenopausal Women.

Authors:  Qing Liu; Alice H Lichtenstein; Nirupa R Matthan; Chanelle J Howe; Matthew A Allison; Barbara V Howard; Lisa W Martin; Carolina Valdiviezo; JoAnn E Manson; Simin Liu; Charles B Eaton
Journal:  Lipids       Date:  2017-07-08       Impact factor: 1.880

7.  Relationships between metabolic syndrome and other baseline factors and the efficacy of ezetimibe/simvastatin and atorvastatin in patients with type 2 diabetes and hypercholesterolemia.

Authors:  Ronald B Goldberg; John R Guyton; Theodore Mazzone; Ruth S Weinstock; Adam B Polis; Diane Tipping; Joanne E Tomassini; Andrew M Tershakovec
Journal:  Diabetes Care       Date:  2010-02-11       Impact factor: 19.112

8.  Immunomodulatory role of high-density lipoproteins: impact on immunosenescence.

Authors:  Anis Larbi; Carl Fortin; Gilles Dupuis; Hicham Berrougui; Abdelouahed Khalil; Tamas Fulop
Journal:  Age (Dordr)       Date:  2014-09-13

9.  The Susceptibility to Diet-Induced Atherosclerosis Is Exacerbated with Aging in C57B1/6 Mice.

Authors:  Olivier Kamtchueng Simo; Hicham Berrougui; Tamas Fulop; Abdelouahed Khalil
Journal:  Biomedicines       Date:  2021-04-29

Review 10.  Sphingomyelin in high-density lipoproteins: structural role and biological function.

Authors:  Roberto Martínez-Beamonte; Jose M Lou-Bonafonte; María V Martínez-Gracia; Jesús Osada
Journal:  Int J Mol Sci       Date:  2013-04-09       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.